These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 12848773)
1. Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction. Rengelshausen J; Göggelmann C; Burhenne J; Riedel KD; Ludwig J; Weiss J; Mikus G; Walter-Sack I; Haefeli WE Br J Clin Pharmacol; 2003 Jul; 56(1):32-8. PubMed ID: 12848773 [TBL] [Abstract][Full Text] [Related]
2. Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein. Kurata Y; Ieiri I; Kimura M; Morita T; Irie S; Urae A; Ohdo S; Ohtani H; Sawada Y; Higuchi S; Otsubo K Clin Pharmacol Ther; 2002 Aug; 72(2):209-19. PubMed ID: 12189368 [TBL] [Abstract][Full Text] [Related]
3. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. Wakasugi H; Yano I; Ito T; Hashida T; Futami T; Nohara R; Sasayama S; Inui K Clin Pharmacol Ther; 1998 Jul; 64(1):123-8. PubMed ID: 9695727 [TBL] [Abstract][Full Text] [Related]
4. The effect of erythromycin and clarithromycin on the pharmacokinetics of intravenous digoxin in healthy volunteers. Tsutsumi K; Kotegawa T; Kuranari M; Otani Y; Morimoto T; Matsuki S; Nakano S J Clin Pharmacol; 2002 Oct; 42(10):1159-64. PubMed ID: 12362931 [TBL] [Abstract][Full Text] [Related]
6. Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans. Gurley BJ; Barone GW; Williams DK; Carrier J; Breen P; Yates CR; Song PF; Hubbard MA; Tong Y; Cheboyina S Drug Metab Dispos; 2006 Jan; 34(1):69-74. PubMed ID: 16221754 [TBL] [Abstract][Full Text] [Related]
7. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893 [TBL] [Abstract][Full Text] [Related]
17. Ritonavir decreases the nonrenal clearance of digoxin in healthy volunteers with known MDR1 genotypes. Penzak SR; Shen JM; Alfaro RM; Remaley AT; Natarajan V; Falloon J Ther Drug Monit; 2004 Jun; 26(3):322-30. PubMed ID: 15167636 [TBL] [Abstract][Full Text] [Related]
18. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [TBL] [Abstract][Full Text] [Related]
19. Effect of NXY-059, a novel neuroprotectant, on the pharmacokinetics of a single dose of digoxin in healthy subjects. Huledal G; Nilsson D; Kågedal M; Reinholdsson I; Cheng YF; Svensson H; Borgå O; van Hout M Curr Med Res Opin; 2007 Jul; 23(7):1531-9. PubMed ID: 17559748 [TBL] [Abstract][Full Text] [Related]
20. Interaction between midazolam and clarithromycin in the elderly. Quinney SK; Haehner BD; Rhoades MB; Lin Z; Gorski JC; Hall SD Br J Clin Pharmacol; 2008 Jan; 65(1):98-109. PubMed ID: 17635500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]